Back to User profile » Dr Yingxin Pang

Papers published by Dr Yingxin Pang:


Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial Carcinoma

Lin Q, Ma X, Hu S, Li R, Wei X, Han B, Ma Y, Liu P, Pang Y

Cancer Management and Research 2021, 13:1955-1965

Published Date: 25 February 2021

Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo

Zhang X, Lu T, Ma Y, Li R, Pang Y, Mao H, Liu P

OncoTargets and Therapy 2020, 13:5069-5082

Published Date: 8 June 2020

Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer [Corrigendum]

Luan W, Pang Y, Li R, Wei X, Jiao X, Shi J, Yu J, Mao H, Liu P

OncoTargets and Therapy 2019, 12:9793-9794

Published Date: 15 November 2019

Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer

Luan W, Pang Y, Li R, Wei X, Jiao X, Shi J, Yu J, Mao H, Liu P

OncoTargets and Therapy 2019, 12:8063-8074

Published Date: 3 October 2019

MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP

Pang Y, Mao H, Shen L, Zhao Z, Liu R, Liu P

OncoTargets and Therapy 2014, 7:587-597

Published Date: 23 April 2014